HIV/AIDS Diagnostics Market

According to a WHO study, approximately 70 million people have been infected with the HIV virus, and 35 million have died as a result of HIV infection. With rising mortality, the government and non-government institutes are taking initiatives and providing funding for diagnostic treatment and prevention of HIV/AIDS. With the advancement of technology, novel diagnostic products are available on the market that requires minimum technical skills, such as portable cell counters and point-of-care rapid diagnostic tests that fasten the diagnosis process. In developing countries such as India and China, with a growing population and rising awareness about HIV, emerging economies will be lucrative markets for HIV/AIDS diagnostics. An increase in the incidence of HIV infection, awareness about HIV/AIDS diagnosis and treatment, and rising research and development for early diagnosis, treatment, and prevention are key factors driving the HIV/AIDS diagnostic market.

The report titled “HIV/AIDS Diagnostics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall HIV/AIDS diagnostics market, along with the market size and estimates for the duration of 2015–2025. The research study in question provides an in-depth examination of multiple market segments based on product type and geography. The product type segment studied for analyzing the overall global HIV/AIDS diagnostics market is majorly segmented into antibody tests, HIV-2 and Group-O diagnostic tests, viral load tests, CD4 testing, early infant diagnostics, and viral identification testing.

Geographically, the global HIV/AIDS diagnostics market is studied for the following regional markets:

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Rest of Europe
• Asia Pacific
• China
• Japan
• Rest of Asia Pacific
• Latin America (LATAM)
• Mexico
• Brazil
• Rest of LATAM
• Middle East and Africa (MEA)
• Saudi Arabia
• South Africa
• the remainder of MEA

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2016–2024 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global HIV/AIDS diagnostics market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global HIV/AIDS diagnostics market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global HIV/AIDS diagnostics market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Based on the type of products, the HIV/AIDS diagnostics market is segmented as follows:

• Antibody Tests
• HIV-1 screening tests
• ELISA
• Rapid Tests
• Home Access: Dried Blood Spots
• HIV-1 Antibody Confirmatory Tests
• Western blot tests
• Indirect Immunofluorescence Assays (IFA)
• Line Immunoassays
• Radio-Immunoprecipitation Assays
• Viral identification testing
• P24 Antigen
• A Qualitative PCR Test
• Viral Culture
• HIV-2 and Group O Diagnostic Tests
• Viral load tests
• CD4 Testing
• Early infant diagnostics

Antibody testing is the most commonly used test for detecting HIV infection. Technological advancement in screening tests, the rising incidence of HIV, and growing awareness about blood donation act as the major drivers of the antibody testing market. Rapid tests and ELISA form the major markets for HIV diagnostic tests. With technological advancements, confirmatory antibody tests have become extremely accurate in providing the end result; for example, a western blot test provides 100% accuracy in post-antibody test result screening. Thus, owing to their high accuracy rate and increase in usage, antibody tests will continue to occupy a dominant position in the forecast period. Monitoring tests such as viral load testing and CD4 testing, which are used to evaluate virologic load and assess the treatment’s safety, are anticipated to be the fastest-growing market.

For the purpose of this study, the global HIV/AIDS diagnostics market is geographically categorized into:

• North America (U.S. and Canada)
• Europe (U.K., Germany, and the Rest of Europe)
• Asia Pacific (China, Japan, and the Rest of APAC)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, South Africa, the rest of the Middle East, and Africa)

In 2016, North America dominated the global HIV/AIDS diagnostics market, followed by Europe. In the North American region, the U.S. occupies the maximum share of the market due to the rise in the prevalence of HIV infection, growing awareness programs, health care access, and national funding for HIV-affected people. At the regional level, Canada has different programs for the treatment of AIDS, which further drives the diagnostic market in the country. Europe is the next important market, driven by factors such as convenient access to healthcare facilities, high healthcare spending, and the introduction of novel treatment opportunities. Asia Pacific is anticipated to have the fastest growth in the HIV/AIDS diagnostic market in the forecast period. Developing countries contribute to the rising number of HIV-AIDS populations, and along with an increase in government initiatives for HIV diagnostic and treatment facilities, rising healthcare expenditure further drives the diagnostic market for the Asia Pacific.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global HIV/AIDS Diagnosticss Market Portraiture
2.2 Global HIV/AIDS Diagnosticss Market Share, by Product Type, 2016 Vs 2025 (Value %)
2.3 Global HIV/AIDS Diagnosticss Market, by Geography, 2016 (Value %)

Chapter 3 Global HIV/AIDS Diagnosticss Market Analysis
3.1 Global HIV/AIDS Diagnosticss Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in HIV/AIDS Diagnostics Market

Chapter 4 Global HIV/AIDS Diagnostics Market Analysis, by Product Type, 2015-2025 (US$ Mn)
4.1 Introduction
4.2 Antibody Tests
4.2.1 HIV-1 Screening Tests
4.2.2 ELISA
4.2.3 Rapid Tests
4.2.4 Home Access Dried Blood Spots
4.3 HIV-1 Antibody Confirmatory Tests
4.3.1 Western Blot Tests
4.3.2 Indirect Immunofluorescence Assays (IFA)
4.3.3 Line Immunoassays
4.3.4 Radio-Immunoprecipitation Assays
4.4 Viral Identification testing
4.4.1 P24 Antigen
4.4.2 Qualitative PCR Test
4.4.3 Viral Culture
4.5 HIV-2 & Group O Diagnostics Tests
4.6 Viral Load Tests
4.7 CD4 Testing
4.8 Early Infant Diagnosticss

Chapter 5 Global HIV/AIDS Diagnostics Market, By Geography, 2015-2025 (US$ Mn)
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of APAC)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Abbvie Inc.
6.3 Alere Inc.
6.4 Apogee Flow Systems
6.5 Beckman Coulter, Inc.
6.6 Becton, Dickinson & Company
6.7 BD Biosciences
6.8 Bio-Rad Laboratories
6.9 BioMerieux
6.10 Bristol-Myers Squibb
6.11 Cepheid
6.12 Chembio Diagnostics Systems
6.13 Daktari Diagnosticss
6.14 Gilead Sciences
6.15 Hologic Inc.
6.16 Merch & Co. Inc
6.17 Mylan Inc
6.18 Janssen Therapeutics

List of Figures

FIG. 1 Global HIV/AIDS Diagnostics Market: Research Methodology
FIG. 2 Global HIV/AIDS Diagnostics Market Share, by Product type, 2016 Vs 2025 (Value %)
FIG. 3 Global HIV/AIDS Diagnostics Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global HIV/AIDS Diagnostics Market, by Geography
FIG. 5 Competitive Analysis: Key Players in Global HIV/AIDS Diagnostics Market
FIG. 6 Global HIV-1 Screening Tests Market, 2015 – 2025 (US$ Mn)
FIG. 7 Global ELISA Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Rapid Tests Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Home Access Dried Blood Spots Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Western Blot Tests Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Indirect Immunofluorescence Assays (IFA) Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Line Immunoassays Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Radio-Immunoprecipitation Assays Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global P24 Antigen Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Qualitative PCR Test Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Viral Culture Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global HIV-2 & Group O Diagnostics Tests Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Viral Load Tests Market, 2015 – 2025 (US$ Mn)
FIG. 19 Global CD4 Testing Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global Early Infant Diagnosticss Market, 2015 – 2025 (US$ Mn)
FIG. 21 Latin America HIV/AIDS Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Middle East & Africa HIV/AIDS Diagnostics Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global HIV/AIDS Diagnostics Market, By Product Type 2015-2025 (US$ Mn)
TABLE 2 Global Antibody Tests Market, 2015-2025 (US$ Mn)
TABLE 1 Global HIV-1 Antibody Confirmatory Tests Market 2015-2025 (US$ Mn)
TABLE 1 Global Viral Identification testing Market 2015-2025 (US$ Mn)
TABLE 2 Global HIV/AIDS Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America HIV/AIDS Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 4 Europe HIV/AIDS Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Asia Pacific HIV/AIDS Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 7 Abbvie Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 8 Alere Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 9 Apogee Flow Systems: Company Snapshot (Business Description; Financial Performance; Product Position Portfolio; News Coverage)
TABLE 10 Beckman Coulter, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 11 Becton, Dickinson & Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 12 BD Biosciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 13 Bio-Rad Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 14 BioMerieux: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 15 Bristol-Myers Squibb: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 Cepheid: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 17 Chembio Diagnostics Systems: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 18 Daktari Diagnosticss: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 Gilead Sciences: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Gilead Sciences: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Merch & Co. Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 22 Mylan Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 23 Janssen Therapeutics: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)